U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H22N2O8S2
Molecular Weight 386.442
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PIPOSULFAN

SMILES

CS(=O)(=O)OCCC(=O)N1CCN(CC1)C(=O)CCOS(C)(=O)=O

InChI

InChIKey=NUKCGLDCWQXYOQ-UHFFFAOYSA-N
InChI=1S/C12H22N2O8S2/c1-23(17,18)21-9-3-11(15)13-5-7-14(8-6-13)12(16)4-10-22-24(2,19)20/h3-10H2,1-2H3

HIDE SMILES / InChI
Piponulfan is neutral, difunctional alkylating derivative of piperazine. This agent was studied for their antineoplastic activity. Piposulfan has been found to be active against the following mouse tumors: sarcoma 180, carcinoma 755, and leukemia 1210. In patients with polycythemia piposulfan produced a response rate similar to that seen with pipobroman, busulfan, and triethylene melamine. However, piposulfan produces noticeably less toxicity than standard recommended doses of either busulfan or triethylene melamine. Various degrees of therapeutie remissions were seen in patients with malignant lymphomas, acute and chronic leukemia, multiple myeloma, adenocarcinomas, epidermoid carcinomas, and various types of sarcomas. The most common adverse reactions to piposulfan involved the hematopoietic (bone marrow depression) and gastrointestinal organs.

Approval Year

PubMed

PubMed

TitleDatePubMed
Midwest cooperative group evaluation of piposulfan (A-20968) in cancer.
1967 May-Jun
The treatment of lepromatous leprosy and erythema nodosum leprosum with the cytostatic drugs Ancyte and Vercyte.
1967 Oct
[Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors].
1968
Effect of piposulfan (NSC-47774) on malignant lymphomas and solid tumors.
1968 Apr
Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774).
1969 Apr
Effects of piposulfan (Ancyte) on protein and DNA synthesis in Ehrlich ascites carcinoma.
1971 Jun 8
[Novel Bis-sulfonic Acid Esters with Cytostatic Activity (author's transl)].
1976
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.
1996 Feb
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice.
1997
Patents

Sample Use Guides

Single dose - 200 mg/kg
Route of Administration: Intraperitoneal
Name Type Language
PIPOSULFAN
INN   MI   USAN  
INN   USAN  
Official Name English
A-20968
Code English
ANCYTE
Brand Name English
1,4-Dihydracryloylpiperazine dimethanesulfonate (ester)
Common Name English
PIPERAZINE, 1,4-BIS(3-((METHYLSULFONYL)OXY)-1-OXOPROPYL)-
Systematic Name English
PIPOSULFAN [MI]
Common Name English
PIPOSULFAN [USAN]
Common Name English
piposulfan [INN]
Common Name English
1,4-DIHYDRACRYLOYLPIPERAZINE DIMETHANESULPHONATE (ESTER)
Common Name English
NSC-47774
Code English
Classification Tree Code System Code
NCI_THESAURUS C222
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
Code System Code Type Description
INN
1959
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
MESH
C107303
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
NCI_THESAURUS
C1783
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL472696
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
MERCK INDEX
m8864
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID80180713
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
EVMPD
SUB09878MIG
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
CAS
2608-24-4
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
PUBCHEM
17458
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
DRUG CENTRAL
3475
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
NSC
47774
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
FDA UNII
VY5DPN1TDU
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY
SMS_ID
100000082215
Created by admin on Fri Dec 15 15:16:30 GMT 2023 , Edited by admin on Fri Dec 15 15:16:30 GMT 2023
PRIMARY